News

ICMR formally inducts LifeCell for COVID-19 diagnostic testing

LifeCell has been formally inducted into the Government's approved laboratories to perform diagnostic and confirmatory tests for detecting Covid-19. 

May 27, 2020

By : Team ABLE

US FDA approves intravenous artesunate to treat severe malaria

Prior to this approval, IV artesunate was only available to patients through the FDA's Expanded Access program, which allowed the U.S. CDC to provide IV artesunate to U.S. patients with severe malaria

May 27, 2020

By : Team ABLE

Glenmark to commence clinical trial on combination of two anti-viral drugs in hospitalized COVID-19 patients

Glenmark Pharmaceuticals has announced that the company will initiate a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir

May 27, 2020

By : Team ABLE

WHO halts hydroxychloroquine trial in COVID-19 patients due to safety concerns

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

May 26, 2020

By : Team ABLE

Novavax initiates phase 1/2 clinical trial of COVID-19 vaccine

Novavax has identified NVXCoV2373 as its lead SARS-CoV-2 candidate following pre-clinical testing that demonstrated high immunogenicity and high levels of neutralizing antibodies.

May 26, 2020

By : Team ABLE